Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch
by
Murphy, M F G
, Walton, R T
, David, S P
, Proctor, M
, Johnstone, E C
, Munafò, M R
in
Administration, Cutaneous
/ Adult
/ Biomedical and Life Sciences
/ Biomedicine
/ Cigarette smoking
/ Clinical trials
/ Dopamine
/ Dopamine D2 receptors
/ Dopamine D4 receptors
/ Dopamine receptors
/ Double-Blind Method
/ Drug addiction
/ Exons
/ Female
/ Follow-Up Studies
/ Gene Expression
/ Gene Frequency
/ Gene polymorphism
/ Genetic aspects
/ Genetic diversity
/ Genetic polymorphisms
/ Genetic Predisposition to Disease
/ Health aspects
/ Human Genetics
/ Humans
/ Logistic Models
/ Male
/ Middle Aged
/ Minisatellite Repeats
/ Nicotine
/ Nicotine - administration & dosage
/ Nicotinic Agonists - administration & dosage
/ Odds Ratio
/ Oncology
/ original-article
/ Pharmacotherapy
/ Physiological aspects
/ Placebos
/ Polymorphism, Genetic
/ Psychopharmacology
/ Receptors, Dopamine D4 - genetics
/ Receptors, Dopamine D4 - metabolism
/ Regression analysis
/ Risk Assessment
/ Risk Factors
/ Smoking - drug therapy
/ Smoking - genetics
/ Smoking - metabolism
/ Smoking Cessation
/ Smoking cessation programs
/ Time Factors
/ Treatment Failure
/ Treatment Outcome
/ White People - genetics
2008
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch
by
Murphy, M F G
, Walton, R T
, David, S P
, Proctor, M
, Johnstone, E C
, Munafò, M R
in
Administration, Cutaneous
/ Adult
/ Biomedical and Life Sciences
/ Biomedicine
/ Cigarette smoking
/ Clinical trials
/ Dopamine
/ Dopamine D2 receptors
/ Dopamine D4 receptors
/ Dopamine receptors
/ Double-Blind Method
/ Drug addiction
/ Exons
/ Female
/ Follow-Up Studies
/ Gene Expression
/ Gene Frequency
/ Gene polymorphism
/ Genetic aspects
/ Genetic diversity
/ Genetic polymorphisms
/ Genetic Predisposition to Disease
/ Health aspects
/ Human Genetics
/ Humans
/ Logistic Models
/ Male
/ Middle Aged
/ Minisatellite Repeats
/ Nicotine
/ Nicotine - administration & dosage
/ Nicotinic Agonists - administration & dosage
/ Odds Ratio
/ Oncology
/ original-article
/ Pharmacotherapy
/ Physiological aspects
/ Placebos
/ Polymorphism, Genetic
/ Psychopharmacology
/ Receptors, Dopamine D4 - genetics
/ Receptors, Dopamine D4 - metabolism
/ Regression analysis
/ Risk Assessment
/ Risk Factors
/ Smoking - drug therapy
/ Smoking - genetics
/ Smoking - metabolism
/ Smoking Cessation
/ Smoking cessation programs
/ Time Factors
/ Treatment Failure
/ Treatment Outcome
/ White People - genetics
2008
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch
by
Murphy, M F G
, Walton, R T
, David, S P
, Proctor, M
, Johnstone, E C
, Munafò, M R
in
Administration, Cutaneous
/ Adult
/ Biomedical and Life Sciences
/ Biomedicine
/ Cigarette smoking
/ Clinical trials
/ Dopamine
/ Dopamine D2 receptors
/ Dopamine D4 receptors
/ Dopamine receptors
/ Double-Blind Method
/ Drug addiction
/ Exons
/ Female
/ Follow-Up Studies
/ Gene Expression
/ Gene Frequency
/ Gene polymorphism
/ Genetic aspects
/ Genetic diversity
/ Genetic polymorphisms
/ Genetic Predisposition to Disease
/ Health aspects
/ Human Genetics
/ Humans
/ Logistic Models
/ Male
/ Middle Aged
/ Minisatellite Repeats
/ Nicotine
/ Nicotine - administration & dosage
/ Nicotinic Agonists - administration & dosage
/ Odds Ratio
/ Oncology
/ original-article
/ Pharmacotherapy
/ Physiological aspects
/ Placebos
/ Polymorphism, Genetic
/ Psychopharmacology
/ Receptors, Dopamine D4 - genetics
/ Receptors, Dopamine D4 - metabolism
/ Regression analysis
/ Risk Assessment
/ Risk Factors
/ Smoking - drug therapy
/ Smoking - genetics
/ Smoking - metabolism
/ Smoking Cessation
/ Smoking cessation programs
/ Time Factors
/ Treatment Failure
/ Treatment Outcome
/ White People - genetics
2008
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch
Journal Article
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch
2008
Request Book From Autostore
and Choose the Collection Method
Overview
Smokers of European ancestry (
n
=720) who participated in a double-blind, randomised, placebo-controlled trial of transdermal nicotine replacement therapy, were genotyped for two functional polymorphisms (variable number of tandem repeats (VNTR) and a C to T transition at position –521 (C-521T)) in the dopamine D4 receptor gene (
DRD4
) gene. Logistic regression models of abstinence at 12- and 26-week follow-ups were carried out separately for each polymorphism. For the
DRD4
VNTR models, the main effect of treatment was significant at both 12-week (
P
=0.001) and 26-week (
P
=0.006) follow-ups, indicating an increased likelihood of successful cessation on active nicotine replacement therapy transdermal patch relative to placebo. The main effect of
DRD4
VNTR genotype was associated with abstinence at 12-week follow-up (
P
=0.034), with possession of one or more copies of the long allele associated with reduced likelihood of cessation (17 vs 23%), but this effect was not observed at 26-week follow-up. For the
DRD4
C-521T models, no main effect or interaction terms involving genotype were retained in the models at either 12- or 26-week follow-up. These data are consistent with observations from studies of the
DRD2
gene that genetic variants related to relatively decreased dopaminergic tone in the mesocorticolimbic system are associated with increased risk for relapse to smoking following a cessation attempt.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ Adult
/ Biomedical and Life Sciences
/ Dopamine
/ Exons
/ Female
/ Genetic Predisposition to Disease
/ Humans
/ Male
/ Nicotine
/ Nicotine - administration & dosage
/ Nicotinic Agonists - administration & dosage
/ Oncology
/ Placebos
/ Receptors, Dopamine D4 - genetics
This website uses cookies to ensure you get the best experience on our website.